Altering the Diet to Rewire Cancer

Case 10-2026: A 70-Year-Old Woman with a Racing Heart, Fatigue, and Dyspnea

Necrolytic Migratory Erythema

Celiac Disease

Erratum for the Research Article "Extracellular vesicle-mediated gene editing for the treatment of nonsyndromic progressive hearing loss in adult mice"

Design of a neutralizing and protective pan-encephalitic alphavirus receptor decoy protein

Real-time intraocular pressure monitoring and responsive drug release in preclinical models by an all-polymer smart contact lens

Keratin 16 inhibits type I interferon responses in differentiating keratinocytes of stressed and diseased skin

A human iPSC model of tauopathies engineered for 4R tau isoform expression endogenously develops late-stage neuronal tau pathology

Pharmacological activation of WASp potentiates macrophage phagocytosis and enhances ibrutinib efficacy against mouse models of brain tumors

Corticosteroid resistance is predetermined by early immune response dynamics at acute graft-versus-host disease onset

Phase 1/1b study of BCMA-targeting bispecific T-cell engager pavurutamab in relapsed/refractory multiple myeloma

Tunneling Nanotube-Mediated Filamin A Transport Mechanosensitively Programs Osteoclastogenesis in Myeloma Bone Disease

A tumor suppressor role of the miR-15b/16-2 cluster in T-cell acute lymphoblastic leukemia

The Ultimate Guide to New USP Bioburden Standards: Navigating Compliance & Market Success in 2026

Digital upgrade to histopathology service reduces wait time for cancer diagnosis

State-of-the-art scanners and advanced image management software allow for more efficient service.

Early epigenetic changes reveal hidden risk in myelodysplstic syndromes

Recipharm reports strong 2025 sustainability performance, advancing industry leadership

Notice Regarding Issuance of New Shares and Secondary Offering of Shares

Notice Regarding Refinancing of Existing Borrowings through a Bridge Loan

Pharmac funds medicine to reduce complications following allogenic haematopoietic stem cell transplant

Pharmac invites feedback before possible medicine brand changes

ESCMID Global 2026: Shionogi presents new real-world data highlighting clinical effectiveness of Fetroja®/Fetcroja® (cefiderocol) in MBL-producing Enterobacterales infections

・Real world evidence study carried out in Spain demonstrates 68% clinical cure rate at day 14, and 8...

SFDA and Saudi Innovation Club Sign MoU to Advance Digital Transformation and Innovation

The Saudi Food and Drug Authority (SFDA) has signed a Memorandum of Understanding (MoU) with the Sau...

News Published on 2026/04/08 タグ University News FY2026 Graduate School Entrance Ceremony held

ISPOR 2026 Plenaries and Speakers Announced

Some Common IBS Treatments Linked to Higher Risk of DeathApril08,2026 02:00 AMAmerica/Los_AngelesA large, long-term study led byCedars-Sinai Health Sciences…Read more

A study from Cedars-Sinai finds long-term use of antidepressants and some antidiarrheal medications...

United Therapeutics Receives FDA Regenerative Medicine Advanced Therapy Designation for miroliverELAP® for Treatment of Acute Liver Failure

UroGen Launches LG-UTUC Luminaries Initiative Recognizing Excellence and Leadership in Treatment of Patients with Low-Grade Upper Tract Urothelial Cancer

Variational AI at WebSummit Vancouver 2026

What’s New for Biologics

Latest news from the Center for Biologics Evaluation and Research

Amneal to Report First Quarter 2026 Results on May 1, 2026

eSubmitter Application History

History of all updates to the application software in reverse chronological order by version number

Clinical Investigator Inspection List E-K

Contains names, addresses, and other information gathered from inspections of clinical investigators...

Clinical Investigator Status (Biologics)

Clinical Investigator Inspection List from inspections of clinical investigators who have conducted...

Crucial Data Solutions Expands TrialKit AI with Study Simulation and Validation Capabilities

Transgene to Participate in Upcoming Investor Meetings

Remarks by FDA Chief Scientist Denise Hinton to the Professional Services Council FedHealth Conference - 03/11/2021

Remarks by FDA Chief Scientist Denise Hinton to the Professional Services Council FedHealth Conferen...

Gilead to Acquire Tubulis Adding Potentially Best-in-Class Antibody-Drug Conjugate and Next Generation Platform to Further Strengthen Oncology PipelineTubuli

Welcoming our new Chief Executive, Mat Shaw

CORMEDIX TO PARTICPATE IN NEEDHAM VIRTUAL HEALTHCARE CONFERENCE

Variational AI releases Enki 4: Major update to foundation model for small- molecule drug discovery

Ergomed Group Announces Board Chair Transition

PathAI and MedStar Health Announce Partnership to Deploy the AISight® Dx Digital Pathology Platform and Advanced AI Applications

Abeona Therapeutics® Announces Appointment of Keith A. Goldan to its Board of Directors

Building Effective Long-Term Follow-Up Strategies in Advanced Therapies

Amneal Announces $2 Million Donation to Support Patient Access to Essential Medicines During Parkinson’s Awareness Month

Natac’s CEO presents SustaiNext as an example of industrial scale-up at the CBE JU Stakeholder Forum 202607/04/2026Industrial biotechnologyAntonio Delgado participated in the panel “From lab to fab: enabling scale up of bio-based…Partners - Natac Group

Antonio Delgado participated in the panel “From lab to fab: enabling scale up of bio-based innovatio...

NervGen Pharma Announces Successful End-of-Phase 2 Meeting and FDA Alignment on RESTORE, a Phase 3 Registrational Study of NVG-291 for Chronic Tetraplegia

YPrime Expands eCOA Platform with Participant Hub

TriNetX Enhances its Ability to Federate Genomics Data Across its Global Network of Providers through the Acquisition of Key Assets of Zetta Genomics

Scientists identify ‘neural fingerprint’ of psychedelic drugs in the brain

Good luck #teamUCLH in the London Landmarks Half Marathon

COVID-19 spring booster available for eligible groups

Skye Bioscience Presenting at GLP-1-Based Therapeutics Summit

SAN DIEGO, April 07, 2026 (GLOBE NEWSWIRE) -- Skye Bioscience, Inc. (Nasdaq: SKYE) (“Skye”) a clinic...

Alloy Therapeutics Enters into Multi-Target Collaboration and License Agreement with Biogen for Use of Alloy’s AntiClastic™ ASO Platform

How stem cell descendants preserve flexibility while maintaining distinct identities

USP Revisions: What They Mean for Injectable Drug Quality and Why Packaging Matters More Than Ever

USP updates on particulate matter standards clarify subvisible particle testing requirements and the...

Read the Press Release

Sanofi’s lunsekimig met primary and key secondary endpoints in phase 2 respiratory studies in asthma...